Awards

Dear Colleagues,

We are pleased to announce that Current Oncology will be awarding two Travel Awards to junior scientists and researchers. The applications will be assessed by an Evaluation Committee consisting of senior scholars from the Current Oncology Editorial Board.

This award will provide financial support for the winners to attend an international conference in the field of clinical oncology practice to be held in 2022, in order to support a podium or poster research presentation.

Candidate Requirements:

– Postdoctoral fellows or PhD students, research fellows or oncology staff in their first 3 years of practice;
– Plans to attend an international conference in 2022 (oral presentation or poster).

Candidate Requirements:

– Postdoctoral fellows or PhD students, research fellows or oncology staff in their first 3 years of practice;
– Plans to attend an international conference in 2022 (oral presentation or poster).

The winners (two awardees) will each be awarded 500 CHF (Swiss francs) and a certificate.

Please submit your applications for the Current Oncology 2021 Travel Awards online by 31 October 2021. Prizes will be awarded on 31 December 2021 and announced on the Current Oncology website.

Dear Colleagues,

On behalf of Editor-in-Chief, Prof. Dr. Sharlene Gill, we wish to acknowledge our reviewers who generously commit their time to support the manuscript peer review process for Current Oncology. The Outstanding Reviewer Awards 2021 recognizes reviewers who have demonstrated exceptional dedication, professionalism, and timeliness in reviewing manuscripts for Current Oncology.

What are the pre-requisites to be eligible for this award?

• All reviewers who have completed a peer review for Current Oncology in 2021 will be included.

Selection Criteria:

• Number of review reports (only first round review reports are considered);
• Review quality based on the rating given in SuSy;
• Time to review completion.

What will the winners receive?

There will be two winners this year, and each will receive the following:

• CHF 500 (Swiss francs);
• An opportunity to publish a paper free of charge in Current Oncology in 2022;
• A certificate of recognition.

When will the winners be announced?

• The winners will be announced in March 2022 on the journal website.

How can I make myself eligible?

• If you have not yet reviewed papers for Current Oncology but would like to do so, you may register as a reviewer via the following link:
  https://susy.mdpi.com/volunteer/profile/edit.

Kind regards,
Current Oncology Editorial Office

Dear Colleagues,

We are pleased to announce that Current Oncology is now inviting nominations for the Current Oncology 2021 Young Investigator Award. This award will be given to one young investigator in recognition of her/his excellence in the field of clinical oncology. All nominations will be assessed by an Evaluation Committee led by Editor-in-Chief, Prof. Dr. Sharlene Gill.

The Prize:

− CHF 2000 (Swiss francs);
− Option to publish one paper free of charge in Current Oncology after peer review before 31 December 2022.

Eligibility and Requirements:

− Have completed oncology training and/or received their PhD no more than 10 years prior to 31 December 2021;
− Must have achieved notable recognition, publications in peer-reviewed journals and a research contribution that has meaningfully advanced the field of clinical oncology;
− Candidates must be nominated by 2 senior scientists/researchers;

List of Documents for Nomination:

–Detailed curriculum vitae, including an updated publication list and a list of the researcher’s own research grants;
− Scanned copy of doctorate certificate;
− Signed nomination letters from two established senior scientists (at least one must be at professor or clinical professor rank).

Schedule:

Open for nominations: 1 April 2021
Nomination deadline: 31 October 2021
Winners announcement: 30 December 2021

How can nominations be submitted?

The nominations must be submitted online.

Contact
Ms. Dimity Wang
Marketing Specialist
Email: [email protected]